You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscle Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging

Recruiting
  • Neoplasms
  • Muscle Neoplasm
  • evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jun 15, 2023

Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Method(s)1 Attribution
  • Method(s)2 Attribution,
  • Colorado Springs, Colorado
    PNAF Medical
Nov 23, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Post-operative Breast Cancer Trial (inspiratory muscle training)

Not yet recruiting
  • Post-operative Breast Cancer
  • inspiratory muscle training
  • (no location specified)
Oct 14, 2023

Colonic Tumors, Rectal Tumors Trial (Aerobic exercise, Progressive stretching)

Not yet recruiting
  • Colonic Neoplasms
  • Rectal Neoplasms
  • Aerobic exercise
  • Progressive stretching
  • (no location specified)
Apr 3, 2023

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

Recruiting
  • Bladder Cancer
  • Pseudomonas aeruginosa
  • Jinan, Shandong, China
    Qilu hospital
Jul 26, 2023

Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

Completed
  • Urinary Bladder Cancer
  • +4 more
  • Neutrophil to lymphocyte ratio
  • Cairo, Egypt
    Ain Shams university
Jul 15, 2023

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

    Recruiting
    • Bladder Cancer
      • Little Rock, Arkansas
      • +2 more
      Aug 6, 2023

      Mobility Limitation, Muscle Relaxation, Kinematics Trial in Cairo (combination of mobilization with movement and muscle energy

      Recruiting
      • Mobility Limitation
      • +4 more
      • combination of mobilization with movement and muscle energy techniques
      • +2 more
      • Cairo, Egypt
        Hany Mohamed Elgohary
      Jun 20, 2023

      Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

      Not yet recruiting
      • Non Muscle Invasive Bladder Cancer
      • +3 more
      • Cretostimogene Grenadenorepvec
      • n-dodecyl-B-D-maltoside
      • (no location specified)
      Oct 30, 2023

      Uromonitor asBiomarker for Optimization of NMIBC Management by

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
        • (no location specified)
        May 9, 2023

        Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

        Not yet recruiting
        • Urinary Bladder Neoplasms
          • (no location specified)
          Feb 14, 2023

          Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

          Recruiting
          • Muscle Invasive Bladder Carcinoma
          • Beijing, China
            Cancer Institute and Hospital, Chinese Academy of Medical Scienc
          Oct 6, 2023

          Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • +2 more
          • PDD-TURBT with hexaminolevulinate (Hexvix®)
          • Power Led Saphira (TM) from KARL STORZ
          • (no location specified)
          Jul 24, 2023

          Analytical Specificity of Bladder EpiCheck Test in Healthy

          Completed
          • Non Muscle Invasive Bladder Cancer
          • Non-Muscle Invasive Bladder Urothelial Carcinoma
          • Bladder EpiCheck
          • San Antonio, Texas
            Urology San Antonio
          Sep 3, 2023

          Pancreatic Cancer Trial in Tainan (pancreatectomy)

          Completed
          • Pancreatic Cancer
          • pancreatectomy
          • Tainan, Taiwan
            National Cheng Kung University Hospital
          Oct 22, 2023

          Colorectal Cancer (CRC), NSCLC (NSCLC) Trial (an enriched high protein and high energy oral nutrition supplement (ONS))

          Not yet recruiting
          • Colorectal Cancer (CRC)
          • Non-small Cell Lung Cancer (NSCLC)
          • an enriched high protein and high energy oral nutrition supplement (ONS)
          • (no location specified)
          Dec 5, 2022

          Breast Carcinoma Trial in Buffalo (Best Practice, Medical Device Usage and Evaluation, Respiratory Muscle Training)

          Not yet recruiting
          • Breast Carcinoma
          • Best Practice
          • +3 more
          • Buffalo, New York
            Roswell Park Cancer Institute
          Mar 29, 2023

          Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

          Terminated
          • Non-muscle Invasive Bladder Cancer (NMIBC)
          • Hyaluronic Acid (HA) sodium salt and Hydeal-D
          • Rozzano, Mi, Italy
            Humanitas Research Hospital
          Sep 29, 2023

          Bladder Cancer Trial in Tianjin (Cadonilimab)

          Recruiting
          • Bladder Cancer
          • Tianjin, Tianjin, China
            Tianjin Medical University Second Hospital
          Aug 23, 2023